|
"lin c"的相关文件
显示项目 431-440 / 556 (共56页)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2012-02 |
Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch
|
Chen, C;Lin, Y;Liu, Y;He, P;Lin, C;Chiu, Y;Wu, C;Cheng, T;Liu, S;Liao, K |
| 國立臺灣科技大學 |
2012 |
Phase compensation for multichannel low-frequency response using minimax approximation
|
Lin, C.;Chen, Y. |
| 國立臺灣科技大學 |
2012 |
Improved transmitter power control schemes for fading channel compensation
|
Lin, C.;Chen, S. |
| 國立臺灣科技大學 |
2012 |
Critical factors and risk allocation for PPP policy: Comparison between HSR and general infrastructure projects
|
Chou, J.-S.;Ping Tserng, H.;Lin, C.;Yeh, C.-P. |
| 臺北醫學大學 |
2012 |
A 10-year follow-up of triple-negative breast cancer patients in Taiwan
|
Lin, C;SY, Chien;SJ, Kuo;LS, Chen;ST, Chen;HW, Lai;TW, Chang;DR, Chen |
| 臺北醫學大學 |
2012 |
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients
|
LH, Yang;HS, Tseng;Lin, C;LS, Chen;ST, Chen;SJ, Kuo;DR, Chen |
| 高雄醫學大學 |
2012 |
Immune nd nflammatory ene ignature n at erebrum n ubarachnoid emorrhage ith icroarray nalysis.?
|
李筑宜;周安國;林敬智;周佳樺;羅永欽;劉安祥;王致仁;Huang, Y;洪純隆;洪義人; Lee, I;Chou, K;Lin, C;Chou, H;Loh, K;Lieu, S;Wang, J;Huang, Y; |
| 臺北醫學大學 |
2012 |
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients
|
Yang, LH;Tseng, HS;Lin, C;Chen, LS;Chen, ST;Kuo, SJ;Chen, DR |
| 臺北醫學大學 |
2012 |
A 10-year follow-up of triple-negative breast cancer patients in Taiwan
|
Lin, C;Chien, SY;Kuo, SJ;Chen, LS;Chen, ST;Lai, HW;Chang, TW;Chen, DR. |
| 國立臺灣大學 |
2012 |
DETECTION OF CAGA EXPRESSION IN GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA-BIOLOGIC SIGNIFICANCE AND CLINICAL IMPLICATION
|
Kuo, S.; Chen, L.; Lin, C.; Wu, M.; Hsu, P.; Tzeng, Y.; Tsai, H.; Wang, H.; Yeh, K.; Cheng, A. |
显示项目 431-440 / 556 (共56页)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每页显示[10|25|50]项目
|
